The tumor-promoting MDSCs can also prepare a microenvironment or a premetastatic niche (pMN), enhance angiogenesis by secreting matrix metalloprotease 9 (MMP9), and promote the tumor mesenchymal-epithelial transition (MET) to facilitate tumor growth [46,47,48]. The gene discussed is MMP9; the disease is neoplasm.